Special Education Session on ASH Clinical Practice Guidelines on Sickle Cell Disease

In 2016, ASH initiated the development of five clinical practice guidelines on sickle cell disease, addressing acute and chronic complications of the disease. Development of the guidelines, including systematic evidence review, was supported by the Mayo Evidence-Based Practice Center. Five guideline panels, which included more than 70 sickle cell disease experts and 10 patient representatives, reviewed evidence and formulated over 50 recommendations. The five guidelines are expected to be submitted for publication in 2019. 

In this special session, speakers will highlight particularly notable recommendations and will discuss important considerations for the practical application of the recommendations in practice.